Fava, Clarissa
 Distribuzione geografica
Continente #
AS - Asia 62
NA - Nord America 52
EU - Europa 25
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 144
Nazione #
US - Stati Uniti d'America 47
SG - Singapore 42
IT - Italia 17
CN - Cina 8
IN - India 4
HK - Hong Kong 3
BR - Brasile 2
CA - Canada 2
GB - Regno Unito 2
IE - Irlanda 2
SE - Svezia 2
VN - Vietnam 2
FR - Francia 1
GT - Guatemala 1
ID - Indonesia 1
JP - Giappone 1
KR - Corea 1
PR - Porto Rico 1
RU - Federazione Russa 1
TT - Trinidad e Tobago 1
Totale 141
Città #
Singapore 34
Ashburn 9
Milan 9
San Jose 4
Hefei 3
Hong Kong 3
Tukwila 3
Beijing 2
Council Bluffs 2
Phoenix 2
Rome 2
Atlanta 1
Boardman 1
Boston 1
Chicago 1
Columbus 1
Dallas 1
Dublin 1
Enterprise 1
Glória de Dourados 1
Greensboro 1
Guayama 1
Haiphong 1
Houston 1
Indianapolis 1
Jacksonville 1
Jakarta 1
Kent 1
Khordha 1
Lakeland 1
Lauterbourg 1
Little Rock 1
London 1
Los Angeles 1
Lucknow 1
Mesa 1
Mississauga 1
Moscow 1
Newport 1
Nghệ An Province 1
Niagara Falls 1
North Bergen 1
Ravenna 1
Resende 1
Salem 1
Santa Clara 1
Savannah 1
Seoul 1
Shelbyville 1
Tabaquite 1
Tokyo 1
Torri del Benaco 1
Totale 114
Nome #
long term follow up of frontiline dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials a real life cohort observational study 92
Real-World Efficacy Profile of Compassionate Use of Asciminib in an Italian, Multi-Resistant Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Patient Population 27
Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A “Campus CML” Study 25
Totale 144
Categoria #
all - tutte 619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 619


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20233 0 0 0 0 1 1 0 0 1 0 0 0
2023/20246 0 1 0 0 0 0 2 0 0 0 0 3
2024/202518 0 0 1 0 3 1 0 0 4 0 7 2
2025/202653 3 1 2 8 23 1 8 2 1 0 3 1
2026/202764 15 6 13 23 7 0 0 0 0 0 0 0
Totale 144